1. Metsovitis T, Bernardi M, Bruckert E, et al. Role of nutrition and healthy lifestyle, for individuals in primary prevention: recent data, gaps in evidence and future directions. Arch Med Sci. 2024;20(5):1385-99. doi:10.5114/aoms/187841.
2. Banach M, Lewek J, Surma S, et al. The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis. Eur J Prev Cardiol. 2023;30(18):1975-85. doi:10.1093/eurjpc/zwad229.
3. Garcia L, Pearce M, Abbas A, et al. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies. Br J Sports Med. 2023;57(15):979-89. doi:10.1136/bjsports-2022-105669.
4. Boraita A, Heras ME, Valenzuela PL, et al. Holter-determined arrhythmias in young elite athletes with suspected risk: Insights from a 20-year experience. Front Cardiovasc Med. 2022;9:896148. doi:10.3389/fcvm.2022.896148.
5. Гаврилова Е. А., Чурганов О. А., Брынцева Е. В. и др. Нарушения ритма сердца как проявление патологического спортивного сердца на разных этапах спортивной подготовки. Современные вопросы биомедицины. 2022;6(1):11-20. doi:10.51871/2588-0500_2022_06_01_11.
6. Wernhart S, Halle M. Atrial fibrillation and long-term sports practice: epidemiology and mechanisms. Clin Res Cardiol. 2015;104(5):369-79. doi:10.1007/s00392-014-0805-0.
7. Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11(9):1156-9. doi:10.1093/europace/eup197.
8. Newman W, Parry-Williams G, Wiles J, et al. Risk of atrial fibrillation in athletes: a systematic review and meta-analysis. Br J Sports Med. 2021;55(21):1233-8. doi:10.1136/bjsports-2021-103994.
9. Ricci C, Gervasi F, Gaeta M, et al. Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis. Eur J Prev Cardiol. 2018;25(8):857-66. doi:10.1177/2047487318768026.
10. Zorzi A, De Lazzari M, Mastella G, et al. Ventricular Arrhythmias in Young Competitive Athletes: Prevalence, Determinants, and Underlying Substrate. J Am Heart Assoc. 2018;7(12):e009171. doi:10.1161/JAHA.118.009171.
11. Sharma S, Drezner JA, Baggish A, et al. International Recommendations for Electrocardiographic Interpretation in Athletes. J Am Coll Cardiol. 2017;69(8):1057-75. doi:10.1016/j.jacc.2017.01.015.
12. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40(3):446-52. doi:10.1016/s0735-1097(02)01977-0.
13. Lakin R, Debi R, Yang S, et al. Differential negative effects of acute exhaustive swim exercise on the right ventricle are associated with disproportionate hemodynamic loading. Am J Physiol Heart Circ Physiol. 2021;320(4):H1261-H1275. doi:10.1152/ajpheart.00603.2020.
14. Sørensen E, Myrstad M, Solberg MG, et al. Right Heart Structure and Function in Lifelong Recreational Endurance Athletes with and without Paroxysmal Atrial Fibrillation. J Am Soc Echocardiogr. 2022;35(12):1259-68. doi:10.1016/j.echo.2022.06.008.
15. La Gerche A, Robberecht C, Kuiperi C. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart. 2010;96(16):1268-74. doi:10.1136/hrt.2009.189621.
16. Bathe-Peters M, Gmach P, Boltz HH. Visualization of β-adrenergic receptor dynamics and differential localization in cardiomyocytes. Proc Natl Acad Sci USA. 2021; 118(23):e2101119118. doi:10.1073/pnas.2101119118.
17. Mitra A, Sarkar A, Borics A. Universal Properties and Specificities of the β2-Adrenergic Receptor-Gs Protein Complex Activation Mechanism Revealed by All-Atom Molecular Dynamics Simulations. Int J Mol Sci. 2021;22(19):10423. doi:10.3390/ijms221910423.
18. Snyder EM, Beck KC, Dietz NM. Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol. 2006;571(Pt 1):121-30. doi:10.1113/jphysiol.2005.098558.
19. Балберова О. В., Быков Е. В. Особенности вегетативной регуляции у спортсменов в зависимости от генотипов rs1042713 гена ADRB2. Российский журнал спортивной науки: медицина, физиология, тренировка. 2025;4(4):1-5. doi:10.24412/2782-6570-2025_04_04_1.
20. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol. 2003;43:381-411. doi:10.1146/annurev.pharmtox.43.100901.13582321.
21. Hesse C, Schroeder DR, Nicholson WT, et al. beta2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade. J Physiol. 2010;588(Pt 14):2669-78. doi:10.1113/jphysiol.2010.190058.
22. Wittwer ED, Liu Z, Warner ND, et al. β-1 and β-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening. Auton Neurosci. 2011;164(1-2):89-95. doi:10.1016/j.autneu.2011.07.004.
23. Ulucan C, Cetintas V, Tetik A, et al. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias. J Cardiovasc Electrophysiol. 2008;19(10):1053-8. doi:10.1111/j.1540-8167.2008.01202.x.
24. Gavin MC, Newton-Cheh C, Gaziano JM, et al. A common variant in the β2-adrenergic receptor and risk of sudden cardiac death. Heart Rhythm. 2011;8(5):704-10. doi:10.1016/j.hrthm.2011.01.003.
25. Ran YQ, Li N, Yang Y, et al. Beta2-adrenoceptor gene variant Arg16Gly is associated with idiopathic ventricular outflow-tract tachycardia. Chin Med J (Engl). 2010;123(17):2299-304.